UBS AM’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.85M | Sell |
|
|||||
|
2023
Q3 | $13M | Sell |
|
|||||
|
2023
Q2 | $11.3M | Hold |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $10.9M | Buy |
|
|||||
|
2022
Q3 | $14.1M | Sell |
|
|||||
|
2022
Q2 | $14.6M | Sell |
|
|||||
|
2022
Q1 | $23.7M | Sell |
|
|||||
|
2021
Q4 | $78.5M | Buy |
|
|||||
|
2021
Q3 | $72M | Sell |
|
|||||
|
2021
Q2 | $69.6M | Sell |
|
|||||
|
2021
Q1 | $79.5M | Sell |
|
|||||
|
2020
Q4 | $108M | Sell |
|
|||||
|
2020
Q3 | $107M | Buy |
|
|||||
|
2020
Q2 | $69M | Buy |
|
|||||
|
2020
Q1 | $46M | Buy |
|
|||||
|
2019
Q4 | $47M | Buy |
|
|||||
|
2019
Q3 | $18.4M | Buy |
|
|||||
|
2019
Q2 | $2.25M | Buy |
|
|||||
|
2019
Q1 | $789K | Buy |
|
|||||
|
2018
Q4 | $292K | Sell |
|
|||||
|
2018
Q3 | $429K | Buy |
|
|||||
|
2018
Q2 | $434K | Buy |
|